| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |